ConductScience.org, home

Paper523358

Pharmacokinetics of amphotericin B and flucytosine.

Polak A. Postgrad Med J, 1979. Cited by 51 papers, by iCite.

Cite this record

ConductScience Library. Pharmacokinetics of amphotericin B and flucytosine. Papers, record 523358. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/523358

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacokinetics of amphotericin B and flucytosine.
PubMed
Journal
Postgrad Med J
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
51
iCite
Relative citation ratio, by iCite
2.51
iCite
Revised in PubMed
2019-05-01
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Polak AA

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Amphotericin BMajor topic
CytosineMajor topic
FlucytosineMajor topic
Animals
Drug Administration Schedule
Half-Life
Humans
Kinetics
Models, Biological
Rabbits
Renal Dialysis

Source PubMed

Download CSV of topics

References12

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1411419Comparative pharmacology of amphotericin B and amphotericin B methyl ester in the non-human primate, Macacca mulatta.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/411419PubMed
2646348Amphotericin B pharmacokinetics in humans.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/646348PubMed
3848928Bone marrow toxicity associated with 5-fluorocytosine therapy.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/848928PubMed
45394441A pharmacologic guide to the clinical use of amphotericin B.J Infect Dis1969https://conductscience.org/library/papers/5394441PubMed
547919785-Fluorocytosine in the treatment of candidiasis with acute renal insufficiency: its kinetics during haemodialysis and peritoneal dialysis.Biomedicine1973https://conductscience.org/library/papers/4791978PubMed
64597703In vitro studies of 5-fluorocytosine resistance in Candida albicans and Torulopsis glabrata.Antimicrob Agents Chemother1972https://conductscience.org/library/papers/4597703PubMed
74507092The kinetics of 5-fluorocytosine elimination in man.Aust N Z J Med1972https://conductscience.org/library/papers/4507092PubMed
84741211Pharmacokinetic studies on the oral antimycotic agent 5-fluorocytosine in individuals with normal and impaired kidney function.Chemotherapy1973https://conductscience.org/library/papers/4741211PubMed
94749757Use of 5-fluorocytosine in patients with impaired renal function.Br Med J1973https://conductscience.org/library/papers/4749757PubMed
104656396[Treatment of cryptococcal meningoencephalitis; value of 5-fluorocytosine].Rev Med Suisse Romande1972https://conductscience.org/library/papers/4656396PubMed
115456013Amphotericin B serum concentrations during therapy.Appl Microbiol1970https://conductscience.org/library/papers/5456013PubMed
125819291Pharmacokinetics of intrathecally administered amphotericin B.Am Rev Respir Dis1969https://conductscience.org/library/papers/5819291PubMed

Download CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.

PMIDTitleJournalYearIn PapersSource
41661352CSF Leukocytes in Intracranial Infections: Diagnostic, Mechanistic, and Therapeutic Insights for Neurocritical Care.Cell Mol Neurobiol2026https://conductscience.org/library/papers/41661352PubMed
40381011Advancing fungal keratitis treatment: transitioning from conventional amphotericin B therapy to nanocarrier-based delivery systems.Naunyn Schmiedebergs Arch Pharmacol2025https://conductscience.org/library/papers/40381011PubMed
36448782Osteoarticular Mycoses.Clin Microbiol Rev2022https://conductscience.org/library/papers/36448782PubMed
36074014Paracoccidioidomycosis: Current Status and Future Trends.Clin Microbiol Rev2022https://conductscience.org/library/papers/36074014PubMed
35326807Isavuconazole in the Treatment of Aspergillus fumigatus Fracture-Related Infection: Case Report and Literature Review.Antibiotics (Basel)2022https://conductscience.org/library/papers/35326807PubMed
33176744Along came a spider: an unusual organism identified in a peritoneal dialysis patient, a case report and literature review.BMC Nephrol2020https://conductscience.org/library/papers/33176744PubMed
31614505Antifungal Drugs: Special Problems Treating Central Nervous System Infections.J Fungi (Basel)2019https://conductscience.org/library/papers/31614505PubMed
31222254Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B.Clin Infect Dis2019https://conductscience.org/library/papers/31222254PubMed
30725316In vitro activity of voriconazole and amphotericin B against Candida albicans, Candida krusei, and Cryptococcus neoformans in human cerebrospinal fluid.Infection2019https://conductscience.org/library/papers/30725316PubMed
28702763Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.Infection2017https://conductscience.org/library/papers/28702763PubMed
24436013In vitro effect of amphotericin B on Candida albicans, Candida glabrata and Candida parapsilosis biofilm formation.Mycopathologia2014https://conductscience.org/library/papers/24436013PubMed
24396137Tissue penetration of antifungal agents.Clin Microbiol Rev2014https://conductscience.org/library/papers/24396137PubMed
8261715Pharmacokinetic optimisation of oral antifungal therapy.Clin Pharmacokinet1993https://conductscience.org/library/papers/8261715PubMed
7492074Antifungal agents in neonatal systemic candidiasis.Antimicrob Agents Chemother1995https://conductscience.org/library/papers/7492074PubMed
6973615Aspergillus granuloma of the trigeminal ganglion.J Neurol Neurosurg Psychiatry1981https://conductscience.org/library/papers/6973615PubMed
6695357Invasive pulmonary aspergillosis in a non-immunosuppressed patient: successful management with systemic amphotericin and flucytosine and inhaled amphotericin.Thorax1984https://conductscience.org/library/papers/6695357PubMed
6439112Quantitative extraction of amphotericin B from serum and its determination by high-pressure liquid chromatography.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6439112PubMed
6301738Clinical pharmacokinetics of systemic antifungal drugs.Clin Pharmacokinet1983https://conductscience.org/library/papers/6301738PubMed
1744306Antibiotic levels in bronchial tree and in serum during selective digestive decontamination.Intensive Care Med1991https://conductscience.org/library/papers/1744306PubMed
1379913Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications.Drugs1992https://conductscience.org/library/papers/1379913PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/523358

GET https://conductscience.org/api/papers/v1/523358/authors